Areas of expertise


Technology & Business Focus

Biolog is a world leader in cell-based phenotypic testing technologies and assays. We have focused our efforts on developing technologies and products to test properties of cells (phenotypes) very simply and efficiently.

Biolog, Inc. is a privately held company that began operations in Northern California in 1984. The company’s product lines have been built upon patented technology that greatly simplifies testing of cells. Biolog’s first products were introduced in 1988 and by 1990 it had established a  growing business in microbiology for the identification and characterization of microbial cells. These products, marketed under the MicroLog™, MicroStation™ and OmniLog® brand names, are sold worldwide through direct sales as well as distribution in over 60 countries. Biolog is the only company providing technology to identify a very wide range and large number of microbial species (> 2900) by  phenotypic testing.

In 1999 Biolog received an SBIR award and began development of  Phenotype MicroArray™ Technology. This technology allows researchers to evaluate thousands of cellular phenotypes simultaneously, in microbial and mammalian cells. Phenotype MicroArrays are being used in a wide range of R&D applications including basic research in cancer, metabolic and mitochondrial disorders, nutrition, toxicology, drug discovery, and bioprocess development.

MitoPlates are the most recent addition to our product portfolio and are used to investigate mitochondrial function. MitoPlates provide a powerful new research tool allowing scientists to run preconfigured sets of 96 assays in one experiment. Mitochondria can be interrogated and characterized by evaluating rates of substrate metabolism, sensitivity to drugs and other chemicals, and effects of mutations in mitochondria-related genes.

In addition to revenue from product sales, Biolog has received funding from private investments and Small Business Innovation Research (SBIR) grants and contracts from the National Institutes for Health (NIH), Department of Energy (DOE), National Aeronautics and Space Administration (NASA) and the National Science Foundation (NSF).




  • Fully automated platform for aerobic identification and phenotypic analysis for microbial and mammalian cells
  • Capacity to incubate and monitor up to 50 MicroPlates
  • Software supporting FDA 21 CFR Part 11 for microbial identification





  • Semi-automated platform for microbial identification and community analysis
  • Software supporting FDA 21 CFR Part 11 for microbial identification








BIOLOG Website

משה שטאובר יישומים ביוטכנולוגיים

Address : 5 Oppenheimer St. Weizmann Science Park Rehovot 76701 ISRAEL Tel: +972-8-9367001 Fax: +972-8-9367002 EMAIL: